FDA adds warnings about memory loss and blood sugar to widely used class of cholesterol drugs

By Associated Press, Published: February 28, WASHINGTON — Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, the most widely prescribed group of cholesterol-lowering medications.